Combined with our robust offering and quality, which is creating more demand and due to our technology platform, we're able to exponentially ramp up capacity, maintain turnaround time within 24 hours, and operate a business, which is generating returns for the shareholders. As Ming mentioned, the recent global crisis has stress-tested the viability of many business models and the same stress has elevated Fulgent technology and science to the forefront as a shining differentiator. Based on the explosive demand we're seeing from the market and the quality of our customers, we continue to see the upward trajectory and transformation of our business continuing for the balance of 2020. We now project test volumes for the year to be over $1.3 million, which translates into over $120 million in revenues.